Cargando…
Activity of PD-1 Inhibitor Combined With Anti-Angiogenic Therapy in Advanced Sarcoma: A Single-Center Retrospective Analysis
Background: Immune checkpoint inhibitors (ICIs) are employed to treat various cancers, including soft tissue sarcomas (STSs), and less than 20% of patients benefit from this treatment. Vascular endothelial growth factor (VEGF) promotes the immunosuppressive tumor microenvironment and contributes to...
Autores principales: | You, Yang, Guo, Xi, Zhuang, Rongyuan, Zhang, Chenlu, Wang, Zhiming, Shen, Feng, Wang, Yan, Liu, Wenshuai, Zhang, Yong, Lu, Weiqi, Hou, Yingyong, Wang, Jing, Zhang, Xuan, Lu, Minzhi, Zhou, Yuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635153/ https://www.ncbi.nlm.nih.gov/pubmed/34869583 http://dx.doi.org/10.3389/fmolb.2021.747650 |
Ejemplares similares
-
Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma
por: Zhang, Chenlu, et al.
Publicado: (2023) -
Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response
por: Wang, Xiang-Xu, et al.
Publicado: (2022) -
Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing
por: Zhang, Chenlu, et al.
Publicado: (2020) -
Metformin Combining PD-1 Inhibitor Enhanced Anti-Tumor Efficacy in STK11 Mutant Lung Cancer Through AXIN-1-Dependent Inhibition of STING Ubiquitination
por: Wang, Zhiguo, et al.
Publicado: (2022) -
A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma
por: Shao, Yebo, et al.
Publicado: (2017)